GUT 润色咨询

GUT

出版年份:1960 年文章数:2644 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181850, encodeId=67832181850e9, content=审稿速度:2.0<br>偏重的研究方向:肿瘤;肠癌<br>经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28ba9068037, createdName=ms9000000250104482, createdTime=Mon Jan 15 19:46:04 CST 2024, time=2024-01-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=968947, encodeId=7ae596894ed5, content=请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89d100209, createdName=paper, createdTime=Thu May 27 16:31:43 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129525, encodeId=3e9121295258d, content=感觉自己的文章做的不错,怎么都不送审,这也太挫败了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d453028965, createdName=129ce8bdm23暂无昵称, createdTime=Mon May 01 10:03:49 CST 2023, time=2023-05-01, status=1, ipAttribution=上海)]
    2024-10-29 ms8000001567143208 来自北京

    大佬们,我投了好几次了,每次都给我说“1. Summary Box

    Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.

    * "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done
    * "What this study adds" - summarise what we now know as a result of this study that we did not know before
    * "How this study might affect research, practice or policy" - summarise the implications of this study

    This will be published as a summary box after the abstract in the final published.
    ”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181850, encodeId=67832181850e9, content=审稿速度:2.0<br>偏重的研究方向:肿瘤;肠癌<br>经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28ba9068037, createdName=ms9000000250104482, createdTime=Mon Jan 15 19:46:04 CST 2024, time=2024-01-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=968947, encodeId=7ae596894ed5, content=请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89d100209, createdName=paper, createdTime=Thu May 27 16:31:43 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129525, encodeId=3e9121295258d, content=感觉自己的文章做的不错,怎么都不送审,这也太挫败了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d453028965, createdName=129ce8bdm23暂无昵称, createdTime=Mon May 01 10:03:49 CST 2023, time=2023-05-01, status=1, ipAttribution=上海)]
    2024-10-07 doctor10 来自四川省

    http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181850, encodeId=67832181850e9, content=审稿速度:2.0<br>偏重的研究方向:肿瘤;肠癌<br>经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28ba9068037, createdName=ms9000000250104482, createdTime=Mon Jan 15 19:46:04 CST 2024, time=2024-01-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=968947, encodeId=7ae596894ed5, content=请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89d100209, createdName=paper, createdTime=Thu May 27 16:31:43 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129525, encodeId=3e9121295258d, content=感觉自己的文章做的不错,怎么都不送审,这也太挫败了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d453028965, createdName=129ce8bdm23暂无昵称, createdTime=Mon May 01 10:03:49 CST 2023, time=2023-05-01, status=1, ipAttribution=上海)]
    2024-07-16 ywh 来自江苏省

    有人投过letter的吗?

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181850, encodeId=67832181850e9, content=审稿速度:2.0<br>偏重的研究方向:肿瘤;肠癌<br>经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28ba9068037, createdName=ms9000000250104482, createdTime=Mon Jan 15 19:46:04 CST 2024, time=2024-01-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=968947, encodeId=7ae596894ed5, content=请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89d100209, createdName=paper, createdTime=Thu May 27 16:31:43 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129525, encodeId=3e9121295258d, content=感觉自己的文章做的不错,怎么都不送审,这也太挫败了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d453028965, createdName=129ce8bdm23暂无昵称, createdTime=Mon May 01 10:03:49 CST 2023, time=2023-05-01, status=1, ipAttribution=上海)]
    2024-07-28 bush 来自江苏省

    可以投case吗?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181850, encodeId=67832181850e9, content=审稿速度:2.0<br>偏重的研究方向:肿瘤;肠癌<br>经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28ba9068037, createdName=ms9000000250104482, createdTime=Mon Jan 15 19:46:04 CST 2024, time=2024-01-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=968947, encodeId=7ae596894ed5, content=请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89d100209, createdName=paper, createdTime=Thu May 27 16:31:43 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129525, encodeId=3e9121295258d, content=感觉自己的文章做的不错,怎么都不送审,这也太挫败了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d453028965, createdName=129ce8bdm23暂无昵称, createdTime=Mon May 01 10:03:49 CST 2023, time=2023-05-01, status=1, ipAttribution=上海)]
    2021-07-18 1484bf18m20暂无昵称

    偏重的研究方向: 消化 ; 胃肠病学
    经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181850, encodeId=67832181850e9, content=审稿速度:2.0<br>偏重的研究方向:肿瘤;肠癌<br>经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28ba9068037, createdName=ms9000000250104482, createdTime=Mon Jan 15 19:46:04 CST 2024, time=2024-01-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=968947, encodeId=7ae596894ed5, content=请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89d100209, createdName=paper, createdTime=Thu May 27 16:31:43 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129525, encodeId=3e9121295258d, content=感觉自己的文章做的不错,怎么都不送审,这也太挫败了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d453028965, createdName=129ce8bdm23暂无昵称, createdTime=Mon May 01 10:03:49 CST 2023, time=2023-05-01, status=1, ipAttribution=上海)]
    2023-07-21 12107b02m29(暂无昵称) 来自河北省

    审稿速度:2.0 | 投稿命中率:5.0
    偏重的研究方向:消化
    经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181850, encodeId=67832181850e9, content=审稿速度:2.0<br>偏重的研究方向:肿瘤;肠癌<br>经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28ba9068037, createdName=ms9000000250104482, createdTime=Mon Jan 15 19:46:04 CST 2024, time=2024-01-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=968947, encodeId=7ae596894ed5, content=请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89d100209, createdName=paper, createdTime=Thu May 27 16:31:43 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129525, encodeId=3e9121295258d, content=感觉自己的文章做的不错,怎么都不送审,这也太挫败了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d453028965, createdName=129ce8bdm23暂无昵称, createdTime=Mon May 01 10:03:49 CST 2023, time=2023-05-01, status=1, ipAttribution=上海)]
    2021-02-22 dr大王

    中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181850, encodeId=67832181850e9, content=审稿速度:2.0<br>偏重的研究方向:肿瘤;肠癌<br>经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28ba9068037, createdName=ms9000000250104482, createdTime=Mon Jan 15 19:46:04 CST 2024, time=2024-01-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=968947, encodeId=7ae596894ed5, content=请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89d100209, createdName=paper, createdTime=Thu May 27 16:31:43 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129525, encodeId=3e9121295258d, content=感觉自己的文章做的不错,怎么都不送审,这也太挫败了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d453028965, createdName=129ce8bdm23暂无昵称, createdTime=Mon May 01 10:03:49 CST 2023, time=2023-05-01, status=1, ipAttribution=上海)]
    2024-01-15 ms9000000250104482 来自广东省

    审稿速度:2.0
    偏重的研究方向:肿瘤;肠癌
    经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181850, encodeId=67832181850e9, content=审稿速度:2.0<br>偏重的研究方向:肿瘤;肠癌<br>经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28ba9068037, createdName=ms9000000250104482, createdTime=Mon Jan 15 19:46:04 CST 2024, time=2024-01-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=968947, encodeId=7ae596894ed5, content=请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89d100209, createdName=paper, createdTime=Thu May 27 16:31:43 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129525, encodeId=3e9121295258d, content=感觉自己的文章做的不错,怎么都不送审,这也太挫败了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d453028965, createdName=129ce8bdm23暂无昵称, createdTime=Mon May 01 10:03:49 CST 2023, time=2023-05-01, status=1, ipAttribution=上海)]
    2021-05-27 paper

    请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!

    21

    展开21条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181850, encodeId=67832181850e9, content=审稿速度:2.0<br>偏重的研究方向:肿瘤;肠癌<br>经验分享:11.22 submission,快两个月了,还是Awaiting Reviewer Scores,虽然中途有圣诞和新年,到现在没有任何消息,有了解的前辈吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28ba9068037, createdName=ms9000000250104482, createdTime=Mon Jan 15 19:46:04 CST 2024, time=2024-01-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=968947, encodeId=7ae596894ed5, content=请问各位前辈们,我投稿后经过awaiting AE assignment, 然后变到Awaiting Reviewer Selection然后就没有变化。想请问下这是已经通过编辑准备送外审了吗?这种还有人遇到过desk rejection吗?谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89d100209, createdName=paper, createdTime=Thu May 27 16:31:43 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129525, encodeId=3e9121295258d, content=感觉自己的文章做的不错,怎么都不送审,这也太挫败了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d453028965, createdName=129ce8bdm23暂无昵称, createdTime=Mon May 01 10:03:49 CST 2023, time=2023-05-01, status=1, ipAttribution=上海)]
    2023-05-01 129ce8bdm23暂无昵称 来自上海

    感觉自己的文章做的不错,怎么都不送审,这也太挫败了

    1

    展开1条回复
共126条页码: 1/13页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分